by Alex Kadhim
Researchers from the University of Lausanne and University Hospital of Zurich in Switzerland demonstrate that PD‑1–targeted CAR‑T cells can selectively reduce HIV reservoir cells and delay...
by Alex Kadhim
Researchers from leading institutions in Shanghai, China, identified a key immune signature driving steroid‑refractory acute graft‑versus‑host disease (SR‑aGvHD), involving expanded CD28+ CD8+...
by ASTCT Talks and Oncology On the Go
In a special ASTCT Talks and Oncology on the Go collaboration, experts discuss a case study examining how CAR T-cell therapy may contribute to rare gastrointestinal T-cell lymphomas. The...
by Margy MacMillan
Last year, Transplantation and Cellular Therapy, ASTCT’s journal, celebrated its 30th year serving the profession. This milestone caused me to reflect on what the journal has meant to the...
by Sophie Paczesny
Sophie Paczesny, MD, PhD, highlights her work advancing GVHD biomarker research and immunotherapy innovation while sharing her priorities as ASTCT board director of laboratory science. She also...
by ASTCT Talks
In this episode of ASTCT Talks, Dr. Nirali Shah is joined by Dr. Christy Duncan and Dr. Sung‑Yun Pai to talk through recent progress in the field and what it actually takes to deliver these...